Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hanaa Rashad"'
Autor:
Hanafy Hafez, Lobna Shalaby, Hammad ، Mahmoud, Mamoud Hamza, Amr Abdallah, Nayra El Shakankiry, Nahla M. El Sharkawy, Hanaa Rashad, Alaa El Haddad
Publikováno v:
Egyptian Journal of Pediatrics. 37:117-125
Autor:
Hanafy Hafez, Iman Zaky, Lobna Shalaby, Nayra El Shakankiry, Youssef Madney, Mahmoud M. Hamza, Sonia Soliman, Hanaa Rashad, Alaa El Haddad, Ahmed El Hemaly
Publikováno v:
Egyptian Journal of Pediatrics. 37:127-134
Autor:
Hanaa Rashad, Hanafy Hafiz, Mahmoud Hammad, Amr Abdallah, Nahla El Sharkawy, Nayra Hamdy, Mahmoud Hamza, Lobna Shalaby, Alaa Elhaddad
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S185
Autor:
Hanaa Rashad, Hanafy Hafiz, Mahmoud Hammad, Amr Abdallah, Nahla El Sharkawy, Nayra Hamdy, Mahmoud Hamza, Lobna Shalaby, Alaa Elhaddad
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S431
Autor:
Eman Nageeb, Iman Zaki, Samah Semary, Hanaa Rashad, Alaa El Hadad, Asmaa Elsheshtawy, Mariam Mostafa, Asmaa Hamouda
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S360-S361
Autor:
Eman Naguib Khorshed, Mohamed Saad, Hanaa Rashad, Reham Khedr, Asmaa Hamoda, Engy Mohamed, Emad Moussa, Madeha Elwakeel
Publikováno v:
Blood. 134:1562-1562
Background & aim:Although 'interim' positron emission tomography (PET) may inform therapeutic decisions, Risk stratification at diagnosis allows earlier and potentially better modification during treatment of HL. the prognosis of HL in our center.In
Autor:
Eman Naguib Khorshed, Madeha Elwakeel, Hanaa Rashad, Asmaa Hamoda, Mohamed Saad, Emad Moussa, Reham Khedr, Engy Mohamed
Publikováno v:
Blood. 134:5280-5280
Background: During the last decades, the prognosis of Hodgkin lymphoma (HL) has been improved significantly with the introduction of effective chemotherapy and the implementation of risk-adapted treatment approaches. Identification of reliable risk f
Autor:
Ola Ahmed, Alaa El Hadad, Iman Zaki, Hala Reda, Naglaa Elkinaai, Samah Semary, Hanaa Rashad, Mohamed Sedki, Asmaa Hamouda
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S348